Suppliers and packages for generic ingredient: larotrectinib sulfate
✉ Email this page to a colleague
larotrectinib sulfate
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861 | NDA | Bayer HealthCare Pharmaceuticals Inc. | 50419-390-01 | 60 CAPSULE in 1 BOTTLE (50419-390-01) | 2019-07-26 |
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861 | NDA | Bayer HealthCare Pharmaceuticals Inc. | 50419-391-01 | 60 CAPSULE in 1 BOTTLE (50419-391-01) | 2019-07-26 |
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861 | NDA | Loxo Oncology, Inc. | 71777-390-01 | 60 CAPSULE in 1 BOTTLE (71777-390-01) | 2018-11-26 |
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861 | NDA | Loxo Oncology, Inc. | 71777-391-01 | 60 CAPSULE in 1 BOTTLE (71777-391-01) | 2018-11-26 |
| Bayer Healthcare | VITRAKVI | larotrectinib sulfate | SOLUTION;ORAL | 211710 | NDA | Bayer HealthCare Pharmaceuticals Inc. | 50419-392-01 | 100 mL in 1 BOTTLE (50419-392-01) | 2019-07-26 |
| Bayer Healthcare | VITRAKVI | larotrectinib sulfate | SOLUTION;ORAL | 211710 | NDA | Bayer HealthCare Pharmaceuticals Inc. | 50419-393-03 | 2 BOTTLE in 1 CARTON (50419-393-03) / 50 mL in 1 BOTTLE (50419-393-02) | 2022-12-06 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
